These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
81 related items for PubMed ID: 2208870
1. Soluble mediators of articular cartilage degradation in juvenile rheumatoid arthritis. Smith RL. Clin Orthop Relat Res; 1990 Oct; (259):31-7. PubMed ID: 2208870 [Abstract] [Full Text] [Related]
7. Interleukin 8 and monocyte chemoattractant protein-1 in patients with juvenile rheumatoid arthritis. Relation to onset types, disease activity, and synovial fluid leukocytes. De Benedetti F, Pignatti P, Bernasconi S, Gerloni V, Matsushima K, Caporali R, Montecucco CM, Sozzani S, Fantini F, Martini A. J Rheumatol; 1999 Feb; 26(2):425-31. PubMed ID: 9972980 [Abstract] [Full Text] [Related]
8. Elevated circulating interleukin-7 levels in patients with systemic juvenile rheumatoid arthritis. De Benedetti F, Massa M, Pignatti P, Kelley M, Faltynek CR, Martini A. J Rheumatol; 1995 Aug; 22(8):1581-5. PubMed ID: 7473488 [Abstract] [Full Text] [Related]
9. Oncostatin M induces angiogenesis and cartilage degradation in rheumatoid arthritis synovial tissue and human cartilage cocultures. Fearon U, Mullan R, Markham T, Connolly M, Sullivan S, Poole AR, FitzGerald O, Bresnihan B, Veale DJ. Arthritis Rheum; 2006 Oct; 54(10):3152-62. PubMed ID: 17009243 [Abstract] [Full Text] [Related]
10. RANTES and monocyte chemoattractant protein 1 as sensitive markers of disease activity in patients with juvenile rheumatoid arthritis: a six-year longitudinal study. Yao TC, Kuo ML, See LC, Ou LS, Lee WI, Chan CK, Huang JL. Arthritis Rheum; 2006 Aug; 54(8):2585-93. PubMed ID: 16868981 [Abstract] [Full Text] [Related]
16. Regulation of cartilage oligomeric matrix protein synthesis in human synovial cells and articular chondrocytes. Recklies AD, Baillargeon L, White C. Arthritis Rheum; 1998 Jun; 41(6):997-1006. PubMed ID: 9627009 [Abstract] [Full Text] [Related]
17. Early degradation of type IX and type II collagen with the onset of experimental inflammatory arthritis. Kojima T, Mwale F, Yasuda T, Girard C, Poole AR, Laverty S. Arthritis Rheum; 2001 Jan; 44(1):120-7. PubMed ID: 11212149 [Abstract] [Full Text] [Related]
18. The role of cytokines in arthritic diseases: in vitro and in vivo measurements of cartilage degradation. Dingle JT, Page Thomas DP, Hazleman B. Int J Tissue React; 1987 Jan; 9(4):349-54. PubMed ID: 3497901 [Abstract] [Full Text] [Related]
19. Monitoring neutrophil activation in juvenile rheumatoid arthritis by S100A12 serum concentrations. Foell D, Wittkowski H, Hammerschmidt I, Wulffraat N, Schmeling H, Frosch M, Horneff G, Kuis W, Sorg C, Roth J. Arthritis Rheum; 2004 Apr; 50(4):1286-95. PubMed ID: 15077313 [Abstract] [Full Text] [Related]
20. Comparison of the degradation of type II collagen and proteoglycan in nasal and articular cartilages induced by interleukin-1 and the selective inhibition of type II collagen cleavage by collagenase. Billinghurst RC, Wu W, Ionescu M, Reiner A, Dahlberg L, Chen J, van Wart H, Poole AR. Arthritis Rheum; 2000 Mar; 43(3):664-72. PubMed ID: 10728761 [Abstract] [Full Text] [Related] Page: [Next] [New Search]